A diazirine-based photoaffinity etoposide probe for labeling topoisomerase II.

[1]  M. Lv,et al.  A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. , 2009, Current medicinal chemistry.

[2]  M. Hashimoto,et al.  Recent Progress in Diazirine‐Based Photoaffinity Labeling , 2008 .

[3]  J. Berger,et al.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology , 2008, Quarterly Reviews of Biophysics.

[4]  J. Berger,et al.  Structural basis for gate-DNA recognition and bending by type IIA topoisomerases , 2007, Nature.

[5]  G. Yan,et al.  A fragmentation study of podophyllotoxin and its 4'-demethyl-4beta-substituted derivatives by electrospray ionization ion-trap time-of-flight tandem mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[6]  H. Wieczorek,et al.  Convenient Synthesis of a [1‐14C]Diazirinylbenzoic Acid as a Photoaffinity Label for Binding Studies of V‐ATPase Inhibitors , 2007 .

[7]  N. Osheroff,et al.  Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme. , 2007, Biochemistry.

[8]  Y. Liu,et al.  Podophyllotoxin: Current Perspectives , 2007 .

[9]  N. Osheroff,et al.  Topoisomerase II and the etiology of chromosomal translocations. , 2006, DNA repair.

[10]  O. Adedayo,et al.  Kinamycins A and C, bacterial metabolites that contain an unusual diazo group, as potential new anticancer agents: antiproliferative and cell cycle effects , 2006, Anti-cancer drugs.

[11]  Frank S. Guziec,et al.  A Structure-Based 3D-QSAR Study of Anthrapyrazole Analogues of the Anticancer Agents Losoxantrone and Piroxantrone , 2006, J. Chem. Inf. Model..

[12]  W. Ens,et al.  Biochemical and Proteomics Approaches to Characterize Topoisomerase IIα Cysteines and DNA as Targets Responsible for Cisplatin-Induced Inhibition of Topoisomerase IIα , 2005, Molecular Pharmacology.

[13]  J. Holthuis.  Etoposide and teniposide , 1988, Pharmaceutisch Weekblad.

[14]  M. Gordaliza,et al.  Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. , 2004, Toxicon : official journal of the International Society on Toxinology.

[15]  C. Monneret,et al.  Etoposide: discovery and medicinal chemistry. , 2004, Current medicinal chemistry.

[16]  M. Endo,et al.  Novel bifunctional probe for radioisotope-free photoaffinity labeling: compact structure comprised of photospecific ligand ligation and detectable tag anchoring units. , 2004, Organic & biomolecular chemistry.

[17]  K. Lee,et al.  Antitumor Agents. 125. New 4β-Benzoylamino Derivatives of 4′-O-Demethyl-4-desoxypodophyllotoxin and 4β-Benzoyl Derivatives of 4′-O-Demethylpodophyllotoxin as Potent Inhibitors of Human DNA Topoisomerase II , 1993, Pharmaceutical Research.

[18]  L. Doyle,et al.  Etoposide: current status and future perspectives in the management of malignant neoplasms , 2004, Cancer Chemotherapy and Pharmacology.

[19]  K. Kohn,et al.  Apoptosis induced by topoisomerase inhibitors. , 2003, Current medicinal chemistry. Anti-cancer agents.

[20]  N. Osheroff,et al.  Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes. , 2003, Current topics in medicinal chemistry.

[21]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[22]  Y. Sadakane,et al.  Photoaffinity labeling in drug discovery and developments: chemical gateway for entering proteomic frontier. , 2002, Current topics in medicinal chemistry.

[23]  A. Valleix,et al.  Synthesis and Tritium Labeling of New Aromatic Diazirine Building Blocks for Photoaffinity Labeling and Cross-Linking , 2001 .

[24]  B. Day,et al.  Synthesis and biological activity of a photoaffinity etoposide probe. , 2001, Bioorganic & medicinal chemistry.

[25]  S. Gasser,et al.  Analysis of etoposide binding to subdomains of human DNA topoisomerase II alpha in the absence of DNA. , 2001, Biochemistry.

[26]  N. Osheroff,et al.  Topoisomerase II-mediated cleavage of plasmid DNA. , 2001, Methods in molecular biology.

[27]  C. Hulme,et al.  Novel applications of resin bound α-amino acids for the synthesis of benzodiazepines (via Wang resin) and ketopiperazines (via hydroxymethyl resin) , 2000 .

[28]  N. Osheroff,et al.  Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. , 2000, Progress in nucleic acid research and molecular biology.

[29]  Deborah Fass,et al.  Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands , 1999, Nature Structural Biology.

[30]  N. Osheroff,et al.  Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance. , 1999, Biochemistry.

[31]  J. Berger.  Structure of DNA topoisomerases. , 1998, Biochimica et biophysica acta.

[32]  J. Nitiss.  Investigating the biological functions of DNA topoisomerases in eukaryotic cells. , 1998, Biochimica et biophysica acta.

[33]  K. Hande,et al.  Etoposide: four decades of development of a topoisomerase II inhibitor. , 1998, European journal of cancer.

[34]  W. Allan,et al.  Mitindomide is a catalytic inhibitor of DNA topoisomerase II that acts at the bisdioxopiperazine binding site. , 1997, Molecular pharmacology.

[35]  N. Osheroff,et al.  Apurinic Sites Are Position-specific Topoisomerase II Poisons* , 1997, The Journal of Biological Chemistry.

[36]  J. Wang,et al.  Recent developments in DNA topoisomerase II structure and mechanism. , 1996, Current opinion in structural biology.

[37]  J. Berger,et al.  Structure and mechanism of DNA topoisomerase II , 1996, Nature.

[38]  N. Osheroff,et al.  Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism (*) , 1995, The Journal of Biological Chemistry.

[39]  J. Brunner,et al.  2-(Tributylstannyl)-4-[3-(trifluoromethyl)-3H-diazirin-3-yl]benzyl Alcohol: A Building Block for Photolabeling and Crosslinking Reagents of Very High Specific Radioactivity , 1995 .

[40]  M. Hashimoto,et al.  Syntheses of Nitro-Substituted Aryl Diazirines. An Entry to Chromogenic Carbene Precursors for Photoaffinity Labeling , 1994 .

[41]  W. Allan,et al.  Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells. , 1994, British Journal of Cancer.

[42]  P. Nielsen,et al.  New compounds related to podophyllotoxin and congeners: synthesis, structure elucidation and biological testing. , 1993, Acta chemica Scandinavica.

[43]  B. Sikic,et al.  Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. , 1990, Experimental hematology.

[44]  L. Zwelling,et al.  Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. , 1989, The Journal of biological chemistry.

[45]  N. Osheroff,et al.  Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. , 1989, Biochemistry.

[46]  N. Osheroff,et al.  Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form. , 1987, Biochemistry.

[47]  N. C. Mathur,et al.  Substituent effects on the rate of carbene formation by the pyrolysis of rigid aryl substituted diazomethanes , 1985 .

[48]  M. Nassal.  4'-(1-Azi-2,2,2-trifluoroethyl)phenylalanine, a photolabile carbene-generating analog of phenylalanine , 1984 .

[49]  M. Nassal,et al.  A carbene-generating photoaffinity probe for beta-adrenergic receptors. , 1983, Biochimica et biophysica acta.

[50]  F. Richards,et al.  3-Trifluoromethyl-3-phenyldiazirine. A new carbene generating group for photolabeling reagents. , 1980, The Journal of biological chemistry.